Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 General Oncology Appoints Abid Ansari as Chief Financial Officer | Contract Pharma
Promotions & Moves

General Oncology Appoints Abid Ansari as Chief Financial Officer

Abid has over 20 years of experience in the biotechnology sector with expertise in financial strategy and corporate development.

General Oncology, Inc., a clinical-stage biopharmaceutical company creating medicines for metastatic cancers, announced the appointment of Abid Ansari as Chief Financial Officer (CFO). 

Abid brings over 20 years of experience in the biotechnology sector, including eight years as a CFO. He has expertise in financial strategy and corporate development for public and private life science companies. 

He has led multiple successful capital-raising initiatives, including initial public offerings (IPOs) and large-scale private funding rounds, and has extensive experience with business development transactions, including merger and acquisition agreements and in-licensing/out-licensing deals.

Jeff Glazier, CEO of General Oncology, said, “With deep expertise in strategic financial leadership, capital raising, and business development, Abid is exceptionally well-suited to help drive our financial strategy as we advance our pipeline. His leadership will be instrumental in securing a strong foundation to support our next phase of growth, including our upcoming clinical readout and a potentially pivotal trial, and ultimately delivering on our mission to bring innovative therapies to cancer patients in need.”

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters